These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26256878)

  • 21. [Diagnosis and management of DIC complicated by hematological malignancies].
    Ikezoe T
    Rinsho Ketsueki; 2016; 57(10):2136-2144. PubMed ID: 27795523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.
    Ikezoe T; Takeuchi A; Isaka M; Arakawa Y; Iwabu N; Kin T; Anabuki K; Sakai M; Taniguchi A; Togitani K; Yokoyama A
    Leuk Res; 2012 Nov; 36(11):1398-402. PubMed ID: 22917769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
    Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
    Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment responses for disseminated intravascular coagulation in 25 children treated with recombinant thrombomodulin: a single institution experience.
    Yagasaki H; Kato M; Shimozawa K; Hirai M; Nishikawa E; Okuma H; Ishii W; Imai Y; Matsumura M; Yonezawa R; Yoshikawa K; Shichino H; Chin M; Mugishima H
    Thromb Res; 2012 Dec; 130(6):e289-93. PubMed ID: 23123162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience in the treatment with recombinant thrombomodulin on disseminated intravascular coagulation with severe urinary tract infection].
    Fumino M; Kurimoto K; Kinoshita N; Kato H; Arima K; Sugimura Y
    Hinyokika Kiyo; 2012 Feb; 58(2):71-4. PubMed ID: 22450831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical Efficacy of Recombinant Human Thrombomodulin for Surgical Patients with Disseminated Intravascular Coagulation Associated with Oncologic Emergency].
    Ikuta L; Nakajima T; Fujikawa M; Nomura K; Matsuki G; Ichise N; Kasai M; Okamoto R; Ikuta S; Nakamoto Y; Aihara T; Yanagi H; Yamanaka N
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1408-1410. PubMed ID: 36733084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant soluble thrombomodulin for postoperative disseminated intravascular coagulation.
    Hashimoto D; Chikamoto A; Miyanari N; Ohara C; Kuramoto M; Horino K; Ohshima H; Baba H
    J Surg Res; 2015 Aug; 197(2):405-11. PubMed ID: 25972310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N; Yoshida S; Ono N; Himeji D; Nagahiro Y; Sayaka Kawano ; Yamashita K; Ikeda N; Uezono S; Ochiai H; Kawano F; Kikuchi I; Ishikawa F; Shimoda K; Ueda A; Akashi K
    J Clin Exp Hematop; 2011; 51(2):101-7. PubMed ID: 22104308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Successful treatment with the combination of recombinant human soluble thrombomodulin and gabexate mesilate in three patients with obstetric disseminated intravascular coagulation].
    Kumura T; Aoyama Y; Ichihara H; Koh S; Mugitani A; Hayakawa H; Yukioka K; Kinoshita D; Nakagawa M; Yamazaki N
    Rinsho Ketsueki; 2011 Feb; 52(2):68-72. PubMed ID: 21403426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Successful treatment using recombinant thrombomodulin for disseminated intravascular coagulation associated with recurrent prosthetic valve endocarditis].
    Masuda S; Adachi O; Ito K; Matsuo S; Hayatsu Y; Suzuki Y; Saito T; Akiyama M; Kumagai K; Motoyoshi N; Kawamoto S; Saiki Y
    Kyobu Geka; 2013 Feb; 66(2):101-5. PubMed ID: 23381354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of Recombinant Thrombomodulin for Sepsis-Associated Disseminated Intravascular Coagulation Caused by Urinary Tract Infections].
    Tachibana A; Iida K; Itami Y; Hashimura M; Toyoshima Y; Hosokawa Y; Fujimoto K
    Hinyokika Kiyo; 2023 Nov; 69(11):309-314. PubMed ID: 38031329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.
    Ikezoe T
    Int J Hematol; 2014 Jul; 100(1):27-37. PubMed ID: 24217998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human thrombomodulin for pneumonia-induced severe ARDS complicated by DIC in children: a preliminary study.
    Hirata N; Ngo DT; Phan PH; Ainai A; Phung TTB; Ta TA; Takasaki J; Kawachi S; Nunoi H; Nakajima N; Dien TM
    J Anesth; 2021 Oct; 35(5):638-645. PubMed ID: 34259911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognosis of disseminated intravascular coagulation associated with hematologic malignancy and its response to recombinant human thrombomodulin.
    Kurita N; Sakamoto T; Kato T; Kusakabe M; Yokoyama Y; Nishikii H; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    Thromb Res; 2019 Jan; 173():57-64. PubMed ID: 30472436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of esophageal cancer with septic disseminated intravascular coagulation treated with recombinant human soluble thrombomodulin during chemoradiation therapy].
    Sasaki K; Okumura H; Uchikado Y; Minami K; Ijichi T; Owaki T; Ishigami S; Natsugoe S
    Gan To Kagaku Ryoho; 2013 Sep; 40(9):1213-5. PubMed ID: 24047782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of bleeding in patients with disseminated intravascular coagulation after receiving surgery and recombinant human soluble thrombomodulin: A cohort study using a database.
    Yamaguchi T; Kitajima Y; Miyauchi Y; Izawa K; Tanaka M; Hirata M; Sadatsuki Y; Ogawa Y
    PLoS One; 2018; 13(10):e0205146. PubMed ID: 30296304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: results of a one-arm prospective trial.
    Tamura K; Saito H; Asakura H; Okamoto K; Tagawa J; Hayakawa T; Aoki N
    Int J Clin Oncol; 2015 Aug; 20(4):821-8. PubMed ID: 25385713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Case report of disseminated carcinomatosis of the bone marrow originating from gastric cancer with cancer-related disseminated intravascular coagulation successfully treated with recombinant human soluble thrombomodulin].
    Kawamoto H; Uchida Y; Ueda S; Yanagita S; Terajima H
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):363-5. PubMed ID: 25812509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of the recombinant thrombomodulin which merged to hematological malignancy].
    Kawasugi K
    Rinsho Byori; 2011 Feb; Suppl 147():181-7. PubMed ID: 21761769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.